In its first-quarter 2025 investor letter, TimesSquare Capital U.S. Focus Growth Strategy highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products ...

Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. Cencora beat analysts’ revenue expectations by 5.2% last quarter ...

Campbell's was similarly down about 1.80%, and Conshohocken-based drug wholesale company Cencora had declined 1.43% at close. Stocks ended another tumultuous day lower as markets reel from President ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

Cencora has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale ...

Cencora (NYSE:COR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding ...

Cencora Inc (NYSE:COR), a prominent player in the Healthcare Providers & Services industry with a market capitalization of $45.7 billion, has been navigating a complex market landscape ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading ...

Forbes contributors publish independent expert analyses and insights. Global pharmaceutical company Cencora, Inc. recently announced the appointment of Pawan Verma as Executive Vice President and ...

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal. RCA is a management services organization that operates a network of retina ...

Cencora's Q4 sales rose 14.7% to $79.1 billion, exceeding $77.65 billion consensus; adjusted EPS increased 16.8% to $3.34. The Retina Consultants of America deal will add nearly 300 retina ...